JPRN-UMIN000024086已完成未知
Phase IIb clinical trial of steroid therapy in patients with HAM(Non progressor) - HAMLET-P
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(2) Patients defined as slow or non-progressor who have received corticosteroids or other treatment targeted to HAM within 48 weeks prior to giving informed consent (3)Patients who have undergone invasive surgeries requiring general anesthesia within 24 weeks prior to giving informed consent (4)Patients who have participated in other treatment studies within 16 weeks prior to giving informed consent (5)Patients who have received live or attenuated/inactivated vaccines within four weeks prior to giving informed consent or plan to receive those during the study period (6)Patients who have received 1.5g/day or more of ascorbic acid, prosultiamine, or pentosan polysulfate within two weeks prior to giving informed consent (7)Patients with a history of acute myocardial infarction (8)Patients with a history of tuberculosis or with active tuberculosis (9)Patients with serious complications (10)Patients with uncontrolled hypertension (11)Patients with uncontrolled electrolyte imbalance (12)Patients with thrombosis (13)Patients with cancer or a history of cancer (14)Patients with peptic ulcer (15)Patients with ATL (16)Patients with poorly controlled eye disease (17)Patients with a history of steroid-induced glaucoma (18)Pregnant or breastfeeding women or patients who may become pregnant or withhold assent to prevention of conception by taking appropriate approach such as condom in cooperation with their partners during the study period (19) Patients with compressive spinal cord lesions such as osteoarthritis of the spine, ossification of posterior longitudinal ligament and ossification of yellow ligament, or joint diseases such as rheumatoid arthritis and osteoarthritis, which preclude assessment using the walk tests or can be worsened by the walk tests (20)Patients with neurological deficits or findings on MRI suggesting it due to disorders other than HAM
研究者
相似试验
已完成
2 期
Phase IIb clinical trial of steroid therapy in patients with HAMJPRN-UMIN000023798St. Marianna University School of Medicine Hospital8
已完成
2 期
Phase IIb clinical trial of steroid therapy in patients with HAM(Slow progressor)HTLV-1-Associated-Myelopathy Tropical Spastic Paraparesis (HAM/TSP)JPRN-UMIN000024085St. Marianna University School of Medicine Hospital40
招募中
2 期
A clinical trial of steroid therapy for patients with FCMD caused by a homozygous(hetrozygous) 3kb insertion in FKTN gene.Fukuyama-type congenital muscular dystrophyJPRN-jRCT2031230211Ishigaki Keiko20
招募中
2 期
A clinical trial of steroid therapy for patients with FCMD caused by a homozygous 3kb insertion in FKTN gene.Fukuyama-type congenital muscular dystrophyJPRN-jRCT2031230210Ishigaki Keiko15
已完成
不适用
A clinical trial of the effects of topical steroid cream (PVA-N11) on atopic dermatitis.Atopic dermatitisJPRN-UMIN000022212Exam CO.,LTD36